CD8A and endometrial cancer: MDSCs in endometrial cancer inhibit cytotoxicity of CD8+ T cells, regulate angiogenesis, form a premetastatic niche and modify stem-like features of cancers cells, which influences endometrial cancer progression, metastasis and even resistance to chemo- and/or radiotherapy [673,674].